Company News
GlobalData first half underpinned by strong subscription revenue
GlobalData reported 8% growth in its underlying revenue in its first half on Monday, to £91. 1m, driven by “strong growth” in subscription revenue at 9%.
Dignity appoints John Castagno as chairman
Funeral services provider Dignity has appointed John Castagno as its new chairman with effect from last Friday.
Persimmon finance director Mike Killoran to retire
Persimmon said on Monday that group finance director Mike Killoran plans to retire early next year after 25 years with the housebuilder.
Plant Health Care H1 revenue growth partially offset by currency headwinds
Agricultural products developer Plant Health Care said on Monday that interim revenue growth had been offset by a modest decrease in gross margins and higher operating expenses.
Heathrow Covid-19 losses reach £2.9bn
Heathrow said on Monday that its cumulative losses from the Covid-19 pandemic have reached £2. 9bn.
Selfridges on the market with £4bn price tag
Iconic London-based department store Selfridges is officially on the market, it was reported on Monday morning, with the Weston family seeking at least £4bn for the chain of four locations.
NewRiver REIT to sell pubs business to Admiral Taverns for £222m
NewRiver REIT has agreed to sell its pubs business, Hawthorn Leisure REIT, to pub operator Admiral Taverns for around £222. 3m in cash.
Ryanair Q1 losses widen but traffic forecast lifted
Budget airline Ryanair reported a widening of its first-quarter losses on Monday as it continued to be impacted by Covid restrictions, but lifted its traffic forecast as bookings have surged in recent weeks.
Carnival recommences voyages from Seattle to Alaska
Cruiseline operator Carnival has kicked off the sailing Alaska season with both its Nieuw Amsterdam and Majestic Princess vessels setting sail over the weekend.
Anglo American Platinum H1 shines on higher prices
Anglo American Platinum reported a sharp rise in first-half earnings on the back of soaring commodity prices.
AstraZeneca's 'Ultomiris' gets EU approval for use in children
AstraZeneca said on Monday that ‘Ultomiris’, or ravulizumab, has been recommended for marketing authorisation in the European Union for expanded use, to include children and adolescents with paroxysmal nocturnal haemoglobinuria (PNH).
Cranswick Q1 revenues rise on strong demand
UK food producer Cranswick on Monday reported a rise in first quarter driven by strong retail demand and increased poultry sales.